Champions Oncology Profit Margin

The latest profit margin for CSBR is -2.57% as of July 2026. That compares with 98.15% in the prior-year period — down 102.6% year over year. That is below the Healthcare sector average of 13.39%. Investors often review this figure alongside Champions Oncology's historical trend and sector peers before judging valuation or financial health.

Over the past year, CSBR's profit margin moved from 98.15% to -2.57% — a 102.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Champions Oncology's valuation or profitability profile.

Against Healthcare companies, CSBR currently prints -2.57% for profit margin, while the sector average sits near 13.39%. That is roughly 119.2% below the sector mean. Large gaps often invite a closer look at Champions Oncology's growth, margins, and balance sheet.

Profit Margin shows how effectively Champions Oncology converts resources into returns. At -2.57%, CSBR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 98.15% in the prior-year period — down 102.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CSBR's profit margin (-2.57%), review year-over-year change from 98.15%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.